From package to patient: webinar set to explore NFC's role in injectables market

Packaging Solutions

MM Pharma & HC Packaging, secondary packaging specialist to the pharmaceutical sector, has announced a collaborative webinar on May 28, 2025, bringing together industry experts to explore the transformative potential of Near Field Communication (NFC) technology in injectable drug delivery systems. The initiative underscores MM Pharma's commitment to cross-industry collaboration and education to support growth across all points in the pharmaceutical supply chain.

The webinar represents a true collaboration with leading smart technology provider NXP Semiconductors and delivery device design specialist Nemera, bringing together complementary expertise to help pharmaceutical companies navigate this emerging technology landscape.

Set against the backdrop of the rapidly expanding injectable drug market – projected to reach over $1 trillion by 2030 according to research firm Markets and Markets – the session will provide pharmaceutical manufacturers with practical insights into implementing connected packaging solutions that enhance both product security and patient experience.

The expert panel features specialists from all three organisations, including Sylvia Kaiser-Kershaw, senior global marketing manager at NXP Semiconductors; Cécile Gross, marketing global category manager at Nemera; and Tiffany Overstreet, global innovation director at MM Pharma & Healthcare Packaging, and Laura López, head of marketing at MM Pharma & Healthcare Packaging, will also participate. Together, they will address key applications of NFC technologies, including anti counterfeiting measures, tamper evidence capabilities, personalised user guidance, and integration strategies for autoinjector solutions.

‘As injectable therapies become increasingly central to modern healthcare, the need for sophisticated packaging solutions has never been more critical,’ said Laura López, head of marketing at MM Pharma & HC Packaging. ‘This collaboration offers pharmaceutical companies a unique opportunity to understand how NFC technology can both protect high value products and significantly improve the patient experience from packaging to administration.

‘We are delighted to have industry leaders NXP and Nemera join us for this important discussion. With injectable therapies representing such significant growth potential in the pharma market, manufacturers need to be at the forefront of packaging innovation. Webinar participants will leave with a clearer understanding of what's possible with NFC and the confidence to start pilot projects, evaluate feasibility, and initiate conversations with internal teams or suppliers.’

The hour long session will cover NFC technology fundamentals, device design principles for improved patient adherence, and practical implementation considerations for pharmaceutical teams evaluating connected packaging solutions. Attendees will gain valuable insights into how connected labels can support real world applications and provide a technical foundation for initiating pilot projects.

With the global injectable market evolving rapidly and patient self-administration becoming increasingly common, connected packaging technologies offer a significant opportunity for pharmaceutical companies seeking competitive differentiation and enhanced user experience.

The webinar will take place on May 28, 2025, at 3 PM CET and is free to attend.

Registration is available at: https://ow.ly/23rl50VKh50